VOLTAREN-XR
LOE ApproachingNDAORALTABLET, EXTENDED RELEASE
Approved
Mar 1996
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 19h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
VOLTAREN-XR is an extended-release oral tablet formulation of diclofenac, a nonsteroidal anti-inflammatory drug (NSAID) approved by Novartis in 1996. The mechanism of action involves inhibition of cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis, thereby decreasing inflammation and pain. The extended-release formulation provides sustained therapeutic levels for chronic pain management.
LOE Approaching
Product is in late-stage lifecycle with moderate competitive pressure (30/100), suggesting defensive positioning and focus on retention rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
VOLTAREN-XR offers limited career growth opportunities as a LOE-approaching product with no linked job postings. Career moves here typically involve defensive commercial strategies, managed care negotiations, and operational efficiency rather than market expansion or innovation.
Brand Manager (Lifecycle Management)Field Sales Representative
Worked on VOLTAREN-XR at Novartis? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.